0001237899-20-000018.txt : 20200507 0001237899-20-000018.hdr.sgml : 20200507 20200507161455 ACCESSION NUMBER: 0001237899-20-000018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200506 FILED AS OF DATE: 20200507 DATE AS OF CHANGE: 20200507 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BROWN MICHAEL S CENTRAL INDEX KEY: 0001174475 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 20856550 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-05-06 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001174475 BROWN MICHAEL S 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2020-05-06 4 M 0 5220 376.69 A 5863 D Common Stock 2020-05-06 4 F 0 3538 555.77 D 2325 D Common Stock 2020-05-06 4 M 0 250 273.67 A 2575 D Common Stock 2020-05-06 4 F 0 123 555.77 D 2452 D Common Stock 2020-05-07 4 S 0 1809 562.0 D 643 D Common Stock 5000 I by SLAT Common Stock 11349 I by Trust Non-Qualified Stock Option (right to buy) 273.67 2020-05-06 4 M 0 250 0.0 D 2024-01-02 Common Stock 250 0 D Non-Qualified Stock Option (right to buy) 376.69 2020-05-06 4 M 0 5220 0.0 D 2027-01-03 Common Stock 5220 2610 D These shares are held in a trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. /s/**Michael S. Brown 2020-05-07